Search

Your search keyword '"Berthold HK"' showing total 184 results

Search Constraints

Start Over You searched for: Author "Berthold HK" Remove constraint Author: "Berthold HK"
184 results on '"Berthold HK"'

Search Results

101. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

102. Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women.

103. The Leu72Met polymorphism of the ghrelin gene is associated with a decreased risk for type 2 diabetes.

104. Combined calcium and vitamin D supplementation is not superior to calcium supplementation alone in improving disturbed bone metabolism in patients with congestive heart failure.

105. Physician gender is associated with the quality of type 2 diabetes care.

106. [Therapy of familial hypercholesterolemia with or without ezetimibe].

107. Effect of a cellulose-containing weight-loss supplement on gastric emptying and sensory functions.

108. Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes.

109. [A telemetrically-guided program for weight reduction in overweight subjects (the SMART study)].

110. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.

111. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.

112. Short-term treatment with ezetimibe, simvastatin or their combination does not alter circulating adiponectin, resistin or leptin levels in healthy men.

113. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.

114. The K121Q polymorphism of the plasma cell glycoprotein-1 gene is not associated with diabetes mellitus type 2 in German Caucasians.

115. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.

116. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

117. Resistin gene 3'-untranslated region +62G-->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population.

118. The peroxisome proliferator-activated receptor delta +294T/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls.

119. The low pressure stent observational trial on the procedural and mid-term outcome of a trapezoid-shaped coronary stent (LOPSTER).

120. Immunosuppressive therapy with everolimus can be associated with potentially life-threatening lingual angioedema.

121. Evaluation of the Coroflex Theca-Stent for reduction of restenosis (ECORI).

122. Clinical and angiographic procedural and mid-term outcome with new versus reused balloon catheters in percutaneous coronary interventions.

123. The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.

124. Adverse reactions to anticoagulants and to antiplatelet drugs recorded by the German spontaneous reporting system.

125. Association between the PPARalpha L162V polymorphism, plasma lipoprotein levels, and atherosclerotic disease in patients with diabetes mellitus type 2 and in nondiabetic controls.

126. Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women.

127. Lymphocyte proliferation and apoptosis in HIV-seropositive and healthy subjects during long-term ingestion of fruit juices or a fruit-vegetable-concentrate rich in polyphenols and antioxidant vitamins.

128. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.

129. Carbamazepine does not alter biochemical parameters of bone turnover in healthy male adults.

130. Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcome.

131. Lipoprotein(a) concentration increases during treatment with carbamazepine.

132. Low serum levels of intact osteocalcin in patients with congestive heart failure.

133. Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion.

134. Restenosis rates with flexible GFX stents (REFLEX): clinical and angiographic results.

135. Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells.

136. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.

137. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women.

138. Carbamazepine increases atherogenic lipoproteins: mechanism of action in male adults.

139. Oral contraceptives moderately effect bone resorption markers and serum-soluble interleukin-6 receptor concentrations.

140. Controlled balloon inflation reduces long-term restenosis after percutaneous transluminal coronary angioplasty.

141. Decrease of elevated N,N-dimethylglycine and N-methylglycine in human immunodeficiency virus infection during short-term highly active antiretroviral therapy.

142. Effects of authentic and VLDL hydrolysis-derived fatty acids on vascular smooth muscle cell growth.

143. Troglitazone and rosiglitazone induce apoptosis of vascular smooth muscle cells through an extracellular signal-regulated kinase-independent pathway.

144. Troglitazone and rosiglitazone inhibit the low density lipoprotein-induced vascular smooth muscle cell growth.

145. Short-term stimulation of vascular smooth muscle cells with platelet-derived growth factor (PDGF)-BB and angiotensin II induces.

146. Is the increase in serum cystathionine levels in patients with liver cirrhosis a consequence of impaired homocysteine transsulfuration at the level of gamma-cystathionase?

147. Physiologic fluctuations of serum estradiol levels influence biochemical markers of bone resorption in young women.

148. Influence of protease inhibitor therapy on lipoprotein metabolism.

149. Neutrophil-elastase in chronic inflammatory bowel disease: a marker of disease activity?

150. Immunoglobulins and IgG subclasses in patients with inflammatory bowel disease.

Catalog

Books, media, physical & digital resources